Product Code: ETC6188203 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Phenylpropanolamine (PPA) is a sympathomimetic drug used in decongestants and appetite suppressants. In Australia, the market for PPA is influenced by its use in over-the-counter medications for colds and flu, as well as in weight loss products. However, concerns over side effects, such as an increased risk of stroke, have led to stricter regulations on its use in certain products. The market is expected to be shaped by ongoing research into safer alternatives and evolving consumer preferences in the pharmaceutical and wellness sectors.
Phenylpropanolamine, previously common in decongestants and appetite suppressants, is facing a constrained market in Australia due to regulatory restrictions and safety concerns. However, there is some demand in veterinary and niche pharmaceutical formulations. The trend is more toward reformulated alternatives with a better safety profile, impacting overall market dynamics.
The Australia Phenylpropanolamine Market faces significant challenges due to safety concerns and regulatory restrictions. Phenylpropanolamine, once commonly used as a decongestant and weight-loss aid, has been linked to health risks such as increased blood pressure and stroke, leading to its removal from many over-the-counter products. Regulatory bodies in Australia have imposed restrictions on its use, limiting the market potential. Moreover, the market is further challenged by the growing shift towards safer, more natural alternatives in the pharmaceutical and dietary supplement sectors.
Investment policies in the phenylpropanolamine market in Australia are influenced by regulatory oversight and consumer safety concerns, particularly given the association of this compound with safety risks related to its use in decongestants and appetite suppressants. The Therapeutic Goods Administration (TGA) strictly regulates the importation and use of such substances. Although policies are increasingly stringent regarding the safety of phenylpropanolamine in over-the-counter products, there are still opportunities for investment in alternative treatments and formulations that comply with Australia health standards.
Phenylpropanolamine (PPA), formerly used in cold medicines and appetite suppressants, is heavily restricted in Australia due to safety concerns. The TGA banned or limited its use following evidence of adverse cardiovascular events. Current government policies discourage its usage, and regulatory oversight ensures it is no longer available in over-the-counter medications.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Phenylpropanolamine Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Phenylpropanolamine Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Phenylpropanolamine Market - Industry Life Cycle |
3.4 Australia Phenylpropanolamine Market - Porter's Five Forces |
3.5 Australia Phenylpropanolamine Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Australia Phenylpropanolamine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Australia Phenylpropanolamine Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Australia Phenylpropanolamine Market Revenues & Volume Share, By Population Type, 2021 & 2031F |
3.9 Australia Phenylpropanolamine Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.10 Australia Phenylpropanolamine Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.11 Australia Phenylpropanolamine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Phenylpropanolamine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Phenylpropanolamine Market Trends |
6 Australia Phenylpropanolamine Market, By Types |
6.1 Australia Phenylpropanolamine Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Australia Phenylpropanolamine Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Australia Phenylpropanolamine Market Revenues & Volume, By Colds, 2021- 2031F |
6.1.4 Australia Phenylpropanolamine Market Revenues & Volume, By Hay fever, 2021- 2031F |
6.1.5 Australia Phenylpropanolamine Market Revenues & Volume, By Upper respiratory allergies, 2021- 2031F |
6.1.6 Australia Phenylpropanolamine Market Revenues & Volume, By Sinusitis, 2021- 2031F |
6.1.7 Australia Phenylpropanolamine Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Phenylpropanolamine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Phenylpropanolamine Market Revenues & Volume, By Human, 2021- 2031F |
6.2.3 Australia Phenylpropanolamine Market Revenues & Volume, By Veterinary, 2021- 2031F |
6.3 Australia Phenylpropanolamine Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Australia Phenylpropanolamine Market Revenues & Volume, By Over the Counter, 2021- 2031F |
6.3.3 Australia Phenylpropanolamine Market Revenues & Volume, By Prescription, 2021- 2031F |
6.4 Australia Phenylpropanolamine Market, By Population Type |
6.4.1 Overview and Analysis |
6.4.2 Australia Phenylpropanolamine Market Revenues & Volume, By Children, 2021- 2031F |
6.4.3 Australia Phenylpropanolamine Market Revenues & Volume, By Adults, 2021- 2031F |
6.5 Australia Phenylpropanolamine Market, By Dosage Form |
6.5.1 Overview and Analysis |
6.5.2 Australia Phenylpropanolamine Market Revenues & Volume, By Solid dosage form, 2021- 2031F |
6.5.3 Australia Phenylpropanolamine Market Revenues & Volume, By Tablets, 2021- 2031F |
6.5.4 Australia Phenylpropanolamine Market Revenues & Volume, By Capsules, 2021- 2031F |
6.5.5 Australia Phenylpropanolamine Market Revenues & Volume, By Liquid dosage form, 2021- 2031F |
6.5.6 Australia Phenylpropanolamine Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Australia Phenylpropanolamine Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Australia Phenylpropanolamine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Australia Phenylpropanolamine Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 Australia Phenylpropanolamine Market Revenues & Volume, By Home healthcare, 2021- 2031F |
6.6.5 Australia Phenylpropanolamine Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Australia Phenylpropanolamine Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Australia Phenylpropanolamine Market Revenues & Volume, By Hospital pharmacies, 2021- 2031F |
6.7.3 Australia Phenylpropanolamine Market Revenues & Volume, By Retail pharmacies, 2021- 2031F |
6.7.4 Australia Phenylpropanolamine Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Australia Phenylpropanolamine Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Phenylpropanolamine Market Import-Export Trade Statistics |
7.1 Australia Phenylpropanolamine Market Export to Major Countries |
7.2 Australia Phenylpropanolamine Market Imports from Major Countries |
8 Australia Phenylpropanolamine Market Key Performance Indicators |
9 Australia Phenylpropanolamine Market - Opportunity Assessment |
9.1 Australia Phenylpropanolamine Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Australia Phenylpropanolamine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Australia Phenylpropanolamine Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Australia Phenylpropanolamine Market Opportunity Assessment, By Population Type, 2021 & 2031F |
9.5 Australia Phenylpropanolamine Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.6 Australia Phenylpropanolamine Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 Australia Phenylpropanolamine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Phenylpropanolamine Market - Competitive Landscape |
10.1 Australia Phenylpropanolamine Market Revenue Share, By Companies, 2024 |
10.2 Australia Phenylpropanolamine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |